Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Ras Gene02:38

The Ras Gene

6.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.5K
Mismatch Repair01:20

Mismatch Repair

5.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.2K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

14.2K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.2K
Mutations01:39

Mutations

84.6K
Overview
84.6K
Mutations in Microorganisms01:18

Mutations in Microorganisms

95
Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
95
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Mechanisms of KIT Receptor Dimerization and Oncogenic Activation Revealed by Multiscale Simulations.

Journal of chemical information and modeling·2026
Same author

In vitro and in silico modelling of ROS1-positive non-small cell lung cancer reveals fusion-dependent tyrosine kinase inhibitor responses.

Molecular oncology·2026
Same author

Correction to "Efficient Protein-Ligand Binding Free Energy Estimation with Coarse-Grained Funnel Metadynamics".

Journal of chemical theory and computation·2026
Same author

Coarse-Grained Simulations Reveal Salt- and Length-Dependent Condensation of G4C2 RNA Repeats.

The journal of physical chemistry letters·2026
Same author

Martini 3 Metabolome.

Journal of chemical theory and computation·2026
Same author

Condensates as Conformation Editors of Disordered Client Proteins.

Journal of the American Chemical Society·2026

Related Experiment Video

Updated: Sep 19, 2025

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

8.8K

Unveiling the Mechanistic Impact of Mutations F2004C/V in the ROS1 Kinase Domain.

Juliana F Vilachã1, Farhan Ul-Haq2, Geert Vandeweyer2

  • 1School of Life Sciences & Department of Chemistry, University of WarwickCoventry Campus, Gibbet Hill Campus, CV4 7AL, Coventry CV4 7AL, U.K.

ACS Omega
|June 16, 2025
PubMed
Summary

ROS1 kinase mutations F2004C/V impact inhibitor response by altering kinase conformations. Understanding these structural changes aids in developing targeted therapies for non-small-cell lung cancer.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.2K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.0K

Related Experiment Videos

Last Updated: Sep 19, 2025

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

8.8K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.2K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.0K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Fusion proteins of the ROS1 kinase domain are key targets in non-small-cell lung cancer (NSCLC).
  • ROS1 mutations, especially F2004C/V, complicate treatment with existing kinase inhibitors.
  • Understanding conformational differences is crucial for effective drug development.

Purpose of the Study:

  • To model the ROS1 kinase domain and differentiate its active and inactive conformations.
  • To investigate the structural impact of F2004C/V mutations on ROS1 kinase activity.
  • To elucidate the mechanism behind differential responses to type I and type II inhibitors.

Main Methods:

  • Development of a ROS1 kinase model.
  • Molecular dynamics simulations to analyze conformational states.
  • Comparative analysis of wild-type and F2004C/V mutant ROS1 structures.

Main Results:

  • A hydrophobic cluster involving DFG residue F2103 defines the active ROS1 conformation.
  • F2004C/V mutations do not affect the active conformation but destabilize F2103 flexibility in the inactive state.
  • Mutations stabilize the hydrophobic cluster in the inactive conformation, impacting inhibitor binding.

Conclusions:

  • A structural model for the inactive ROS1 kinase domain is proposed, highlighting differences from the active state.
  • The F2004C/V mutations provide insights into differential responses to type I and type II inhibitors.
  • Findings offer a mechanistic basis for designing next-generation ROS1-targeted therapies for NSCLC.